Patents by Inventor Ghazaleh Sadri-Vakili

Ghazaleh Sadri-Vakili has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230149345
    Abstract: The present disclosure relates to a method of treating one or more inflammation conditions induced by a coronavirus infection in a subject in need thereof, comprising administering a pharmaceutical composition comprising a compound of Formula I or Formula II, wherein R1 is halogen, OH, or —OC(O)C1-5alkyl, R2 and R3 are each independently selected from CO2R4 and CH2OR5; R4 is Li, Na, K, H, C1-5-alkyl, or —CH2CO(C1-5alkyl); and R5 is H or —C(O)(C1-5alkyl), or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 5, 2021
    Publication date: May 18, 2023
    Inventors: David R. Elmaleh, Ana Griciuc, Ghazaleh Sadri-Vakili, Sabrina Paganoni, Rudolph E. Tanzi
  • Publication number: 20040082554
    Abstract: The invention relates to neuroactive steroid compounds that are useful in modulating CNS effects, diseases or disease symptoms. The invention also relates to use of the compounds in methods of treating or preventing disease or disease symptoms, and methods of modulating or mediating CNS effects or processes.
    Type: Application
    Filed: November 14, 2003
    Publication date: April 29, 2004
    Inventors: David F Farb, Ghazaleh Sadri-Vakili, Robert Christopher Pierce, David W Johnson, Terrell T Gibbs